Disruption of Circadian Clock Induces Abnormal Mammary Morphology and Aggressive Basal Tumorigenesis by Enhancing LILRB4 Signaling

Olajumoke Ogunlusi,Mrinmoy Sarkar,Arhit Chakrabarti,Devon J Boland,Tristan Nguyen,James Sampson,Christian Nguyen,Danielle Fails,Yava Jones-Hall,Loning Fu,Bani Mallick,Alex Keene,Jeff Jones,Tapasree Roy Sarkar
DOI: https://doi.org/10.1101/2024.03.19.585534
2024-04-26
Abstract:Epidemiological studies have shown that circadian rhythm disruption (CRD) is associated with the risk of breast cancer. However, the role of CRD in mammary gland morphology and aggressive basal mammary tumorigenesis and the molecular mechanisms underlying CRD and cancer risk remain unknown. To investigate the effect of CRD on aggressive tumorigenesis, a genetically engineered mouse model that recapitulates the human basal type of breast cancer was used for this study. The effect of CRD on mammary gland morphology was investigated using wild-type mice model. The impact of CRD on the tumor microenvironment was investigated using the tumors from LD12:12 and CRD mice via scRNA seq. ScRNA seq was substantiated by multiplexing immunostaining, flow cytometry, and realtime PCR. The effect of LILRB4 immunotherapy on CRD-induced tumorigenesis was also investigated. Here we identified the impact of CRD on basal tumorigenesis and mammary gland morphology and identified the role of LILRB4 on CRD-induced lung metastasis. We found that chronic CRD disrupted mouse mammary gland morphology and increased tumor burden, and lung metastasis and induced an immunosuppressive tumor microenvironment by enhancing LILRB4a expression. Moreover, CRD increased the M2-macrophage and regulatory T-cell populations but decreased the M1-macrophage populations. Furthermore, targeted immunotherapy against LILRB4 reduced CRD-induced immunosuppressive microenvironment and lung metastasis. These findings identify and implicate LILRB4a as a link between CRD and aggressive mammary tumorigenesis. This study also establishes the potential role of the targeted LILRB4a immunotherapy as an inhibitor of CRD-induced lung metastasis.
Cancer Biology
What problem does this paper attempt to address?
This paper mainly explores how Circadian Rhythm Disruption (CRD) leads to the occurrence of breast cancer, especially the abnormal proliferation of basal-like breast tumors and lung metastasis, and reveals the underlying molecular mechanisms. The study used a transgenic mouse model that simulates human basal-like breast cancer and found that CRD disrupts the structure of the mouse mammary gland, increases tumor burden and lung metastasis, and induces an immunosuppressive tumor microenvironment. Specifically, CRD promotes this process by enhancing the signaling pathway of Leukocyte Immunoglobulin-like Receptor B4 (LILRB4). The authors observed a decrease in the number of branches and terminal buds in the mammary gland of chronic CRD mice, accompanied by ductal hyperplasia. In addition, CRD increases tumor growth rate, accelerates tumor onset, and promotes lung metastasis. In the tumor microenvironment of CRD mice, LILRB4 expression is upregulated, leading to an increase in M2 macrophages and regulatory T cells, while M1 macrophages decrease. This suggests that CRD may promote tumor development through immunosuppressive effects. Further research revealed that immune therapy targeting LILRB4 can reduce CRD-induced immunosuppressive microenvironment and lung metastasis, indicating that LILRB4 may be a potential target for treating CRD-related breast cancer. This work provides new insights into the relationship between CRD and breast cancer and proposes LILRB4 immune therapy as a possible strategy to inhibit CRD-induced lung cancer metastasis.